ANTHRACYCLINE CARDIOTOXICITY: THE PHARMACOKINETICS AND PHARMACODYNAMICS OF DEXRAZOXANE AND ITS OPEN RING METABOLITE

被引：0
|
作者：
Jirkovska-Vavrova, A. [1 ]
Jirkovsky, E. [2 ]
Stariat, J. [1 ]
Jansova, H. [1 ]
Roh, J. [1 ]
Lencova-Popelova, O. [2 ]
Kovarikova, P. [1 ]
Sterba, M. [2 ]
Simunek, T. [1 ]
机构：
[1] Charles Univ Prague, Fac Pharm Hradec Kralove, Hradec Kralove, Czech Republic
[2] Charles Univ Prague, Fac Med Hradec Kralove, Hradec Kralove, Czech Republic
来源：
HEART | 2014年 / 100卷
关键词：
D O I：
10.1136/heartjnl-2014-306916.20
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
020
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Pharmacokinetics of gemcitabine and its primary metabolite in dogs after intravenous bolus dosing and its in vitro pharmacodynamics
    Freise, KJ
    Martín-Jiménez, T
    JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2006, 29 (02) : 137 - 145
  • [42] Comparison of protective effects of two iron chelating compounds - deferiprone and dexrazoxane - against chronic anthracycline cardiotoxicity
    Popelova, Olga
    Sterba, Martin
    Simunek, Tomas
    Guncova, Ivana
    Mazurova, Yvona
    Hroch, Milos
    Adamcova, Michaela
    Gersl, Valdimir
    TOXICOLOGY LETTERS, 2008, 180 : S56 - S56
  • [43] Dexrazoxane Significantly Reduces Anthracycline-induced Cardiotoxicity in Pediatric Solid Tumor Patients: A Systematic Review
    Liesse, Kelly
    Harris, Jamie
    Chan, Megan
    Schmidt, Mary L.
    Chiu, Bill
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2018, 40 (06) : 417 - 425
  • [44] Pharmacokinetics and pharmacodynamics of enalapril and its active metabolite, enalaprilat, at four different doses in healthy horses
    Gomez-Diez, Manuel
    Munoz, Ana
    Serrano Caballero, Juan Manuel
    Riber, Cristina
    Castejon, Francisco
    Manuel Serrano-Rodriguez, Juan
    RESEARCH IN VETERINARY SCIENCE, 2014, 97 (01) : 105 - 110
  • [45] Early and delayed cardioprotective intervention with dexrazoxane each show different potential for prevention of chronic anthracycline cardiotoxicity in rabbits
    Jirkovsky, Eduard
    Lencova-Popelova, Olga
    Hroch, Milos
    Adamcova, Michaela
    Mazurova, Yvona
    Vavrova, Jaroslava
    Micuda, Stanislav
    Simunek, Tomas
    Gersl, Vladimir
    Sterba, Martin
    TOXICOLOGY, 2013, 311 (03) : 191 - 204
  • [46] Sex- and dose-dependency in the pharmacokinetics and pharmacodynamics of (+)-methamphetamine and its metabolite (+)-amphetamine in rats
    Milesi-Hallé, A
    Hendrickson, HP
    Laurenzana, EM
    Gentry, WB
    Owens, SM
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2005, 209 (03) : 203 - 213
  • [47] Pharmacodynamics and Pharmacokinetics of Injectable Pimobendan and Its Metabolite, O-Desmethyl-Pimobendan, in Healthy Dogs
    Pichayapaiboon, Poonavit
    Tantisuwat, Lalida
    Boonpala, Pakit
    Saengklub, Nakkawee
    Boonyarattanasoonthorn, Tussapon
    Khemawoot, Phisit
    Kijtawornrat, Anusak
    FRONTIERS IN VETERINARY SCIENCE, 2021, 8
  • [48] Comparative pharmacokinetics and pharmacodynamics of remifentanil, its principle metabolite (GR90291) and alfentanil in dogs
    Hoke, JF
    Cunningham, F
    James, MK
    Muir, KT
    Hoffman, WE
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1997, 281 (01): : 226 - 232
  • [49] Pharmacokinetics, pharmacodynamics and clinical use of trazodone and its active metabolite m-chlorophenylpiperazine in the horse
    Davis, J. L.
    Schirmer, J.
    Medlin, E.
    JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2018, 41 (03) : 393 - 401
  • [50] Late anthracycline cardiotoxicity protection by dexrazoxane (ICRF-187) in pediatric patients: echocardiographic follow-up
    Elbl, L
    Hrstkova, H
    Tomaskova, I
    Michalek, J
    SUPPORTIVE CARE IN CANCER, 2006, 14 (02) : 128 - 136
12345